Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- The lower commodity prices go, the better for those companies that consume them. That was Jim Cramer's bottom line on Mad Money Thursday. Sure, some companies suffer as commodity prices fall, but there are a lot more consumers of commodities than producers.
That's why the markets are getting it all wrong. It's commodity inflation we should fear, not deflation. Investors are forgetting their history if they think cheap commodities are anything but a good thing for our economy.
Cramer took viewers on a trip down memory lane to remind them of 1987, when there were price increases every month, sometimes every week, for everything from paper and cardboard, to chemicals, lumber and more. Shortly thereafter, the market crashed.
Fast forward to 2008, when again commodities like oil, copper, gold, coal and steel were rising on a daily basis. This was part of the reason the Federal Reserve kept raising interest rates, to rein in the inflation. But in the end, the market crashed.
That brings us to today, when commodities aren't rising, they're falling, allowing consumers and small businesses to buy more for less. That's great news for restaurants, as consumers have more cash. It's great for automakers who pay less for steel. And it's great for the airlines, like Southwest Airlines (LUV - Get Report), Spirit Airlines (SAVE - Get Report) and American Airlines (AAL), all of which pay less for fuel.
Sure, some companies do get hurt in a falling price environment, and yes, the oil patch remains under pressure, but Cramer concluded there are far more winners than losers in this environment, and investors need to take notice.
Executive Decision: Tim Mayleben
For his "Executive Decision" segment, Cramer spoke with Tim Mayleben, president and CEO of Esperion Therapeutics (ESPR), the red-hot biotech that conducted a very successful secondary offering of shares last week.
Mayleben said that Experion is very excited about its anti-cholestrol drug, currently named ETC-1002. He said while the drug has a terrible name, it's one of the most attractive drugs under development today, one that is both safe and well tolerated and can reduce bad cholesterol either by itself or in conjunction with a statin.
Perhaps the most exciting feature of ETC-1002 is it comes in a once-daily pill rather than an injection that typically involves a trip to a doctor's office. Mayleben said patients overwhelmingly prefer a pill over an injection.
Cramer agreed, saying Esperion's stock is not done going higher as this revolutionary drug could easily be worth billions of dollars.
Off the Charts
In the "Off The Charts" segment, Cramer went head to head with Real Money colleague Carly Garner over the direction of the markets, using the S&P 500 as her guide.
Garner noted that historically, the period between March 15 and the end of April has been very good for the markets, rising 13 of the past 15 years. But seasonality aside, the S&P is looking good, with a strong floor of support at 2,040, a level which was tested, and held, just last week.
With the RSI momentum indicator indicating that the path of least resistance for the S&P being higher, Garner felt a rally to the 2,170 or 2,180 level was certainly possible. At that level, profit taking would be advised.
What about downside risk? In the event of a negative geo-political event, Garner felt the index would only fall back to one of its many support levels at 1,987, 1,947 and 1,880.
Cramer agreed with Garner that the bull appears to be alive and well, despite what seems like daily, and sometimes hourly, volatility.
Off the Tape
In the "Off The Tape" segment, Cramer spoke with Bastian Lehmann, co-founder and CEO of the privately held Postmates, the delivery service that promises to get you what in need, usually in less than an hour. Wednesday, Postmates inked a deal with Starbucks (SBUX - Get Report) to deliver coffee to your door in select markets.
Lehmann said yesterday was a very big day for his company. He said Starbucks chose to partner with Postmates because his company is a people company, caring deeply about its drivers and riders but also because Postmates has a fast and efficient operation.
When asked about the company's growth, Lehmann noted that Postmates added 18 new markets just last year and it knows what it takes to find customers in new markets because the company continues to grow this year.
Lehmann feels the Starbucks partnership will appeal to a lot of people and his company plans on having price points that are attractive to everyone.
Executive Decision: Dan Leever
In his second "Executive Decision" segment, Cramer sat down with Dan Leever, president and CEO of Platform Specialty Products (PAH), a specialty chemical provider with shares that are up 12% so far in 2015.
Leever explained that his company acquires high-cash-flow businesses that are people oriented, ones that provide high levels of service that afford a sustainable advantage. His company has businesses that serve the oil and gas industry as well as coatings, among others.
Leever said while Platform is a U.S.-centric company, it trades in 180 currencies around the globe, too.
When asked about one of Platform's investors, Bill Ackman, Leever said Ackman is not invested in an activist role but as a long-term backer of the company.
Before concluding, Leever made a bold $200 price target for his now $26 stock, noting that Platform will be looking to issue more equity as it makes its next acquisition.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.